PUT - SPRINTER OPEN END - AMGEN | Market Closed - Boerse Frankfurt Warrants 01:53:06 2024-07-05 pm EDT | ||
| 1.71 EUR | -9.52% |
|
| Current month | +13.25% | ||
| 1 month | -6.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 1.71 | -9.52% |
| 24-07-04 | 1.89 | +2.16% |
| 24-07-03 | 1.85 | +8.19% |
| 24-07-02 | 1.71 | +1.79% |
| 24-07-01 | 1.68 | +11.26% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 01:53 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM9TYB |
| ISIN | DE000VM9TYB7 |
| Date issued | 2024-02-06 |
| Strike | 328.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.74 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.37 € |
|---|---|
| Lowest since issue | 0.62 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Certificates
- Certificat
